Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi (MGX) Other Non-Current Liabilities (2023 - 2025)

Metagenomi (MGX) has disclosed Other Non-Current Liabilities for 3 consecutive years, with $2.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Other Non-Current Liabilities fell 2.84% to $2.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.0 million, a 2.84% decrease, with the full-year FY2025 number at $2.0 million, down 2.84% from a year prior.
  • Other Non-Current Liabilities was $2.0 million for Q4 2025 at Metagenomi, up from $1.9 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $5.1 million in Q4 2023 to a low of $1.9 million in Q3 2025.
  • A 3-year average of $3.0 million and a median of $2.2 million in 2025 define the central range for Other Non-Current Liabilities.
  • Peak YoY movement for Other Non-Current Liabilities: plummeted 60.43% in 2024, then dropped 2.84% in 2025.
  • Metagenomi's Other Non-Current Liabilities stood at $5.1 million in 2023, then tumbled by 60.43% to $2.0 million in 2024, then fell by 2.84% to $2.0 million in 2025.
  • Per Business Quant, the three most recent readings for MGX's Other Non-Current Liabilities are $2.0 million (Q4 2025), $1.9 million (Q3 2025), and $2.2 million (Q2 2025).